MedTrace Logo

Role of MSCT Volumetry in Assessment of Brain Atrophy in Septic Patients

NCT06112119 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2023-11-01

No results posted yet for this study

Summary

assessment of brain atrophy associated with septic ICU patients by using MSCT Volumetry

Conditions

  • Sepsis-Associated Encephalopathy

Interventions

DEVICE

MSCT

Using Semi-automatic MSCT Volumetry in assessment of brain atrophy associated with septic ICU patients

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nada mohamed abdelmoneim · Assiut University

  • sherif mohamed abdelaal · Assiut University

  • samy abdelaziz · Assiut University

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-11-01
Completion
2024-12-30
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06112119 on ClinicalTrials.gov